Ligand id: 10208

Name: ibalizumab

Bioactivity Comments
Burkly et al.'s original analysis of ibalizumab (therein named 5A8) binding to CD4 expressed on CHO cells gives an EC50 of ~1μg/ml [1].
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CD4 Hs Antibody Binding - - - 1